scholarly article | Q13442814 |
P50 | author | Adria Giacca | Q80162695 |
P2093 | author name string | Elena Bogdanovic | |
I George Fantus | |||
Tony K T Lam | |||
Neehar Gupta | |||
Zhiwen Yu | |||
C Andrew Haber | |||
Tracy Goh | |||
P2860 | cites work | Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats | Q24563606 |
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning | Q24564978 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
Effects of knockout of the protein kinase C beta gene on glucose transport and glucose homeostasis | Q28587797 | ||
Role of free radicals and catalytic metal ions in human disease: an overview | Q29618022 | ||
Protein oxidation in aging, disease, and oxidative stress | Q29619442 | ||
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
Pharmacokinetics of N-acetylcysteine in man. | Q34191138 | ||
Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. | Q34237007 | ||
Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes | Q34330770 | ||
Oxidative stress and diabetic vascular complications | Q34391178 | ||
The role of taurine in diabetes and the development of diabetic complications | Q34465081 | ||
Protein kinase C activation and the development of diabetic complications | Q34469779 | ||
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus | Q34541876 | ||
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants | Q35634487 | ||
In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats | Q35750029 | ||
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity | Q35768419 | ||
Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. | Q36590164 | ||
Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites | Q37351595 | ||
Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance | Q37358652 | ||
Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity | Q37393990 | ||
Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C | Q39575897 | ||
Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways | Q40912879 | ||
Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance | Q40934232 | ||
Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). | Q41020366 | ||
Contributions to senescence: non-enzymatic glycosylation of proteins | Q41452034 | ||
Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing | Q41845928 | ||
The antioxidant action of taurine, hypotaurine and their metabolic precursors | Q41878907 | ||
High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes | Q42489573 | ||
alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation | Q42510095 | ||
Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury | Q42816281 | ||
Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation | Q42817438 | ||
Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes | Q42826146 | ||
Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake | Q42858446 | ||
Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). | Q43681994 | ||
Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats | Q43777075 | ||
Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep | Q43804496 | ||
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians | Q43850960 | ||
The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. | Q51558704 | ||
Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. | Q51583621 | ||
Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. | Q51592930 | ||
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. | Q54080708 | ||
Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. | Q54318715 | ||
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia | Q58829265 | ||
Meal-Generated Oxidative Stress in Type 2 Diabetic Patients | Q58829300 | ||
Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance | Q59150861 | ||
P433 | issue | 4 | |
P921 | main subject | hyperglycemia | Q271993 |
acetylcysteine | Q375613 | ||
insulin resistance | Q1053470 | ||
preproinsulin | Q7240673 | ||
P304 | page(s) | E744-53 | |
P577 | publication date | 2003-06-10 | |
P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
P1476 | title | N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress | |
P478 | volume | 285 |
Q47982355 | A conceptual framework for predicting and addressing the consequences of disease-related microvascular dysfunction. |
Q52680307 | Ameliorative effects of taurine against diabetes: a review. |
Q47884952 | An NMR-Based Metabolomic Approach to Unravel the Preventive Effect of Water-Soluble Extract from Dendrobium officinale Kimura & Migo on Streptozotocin-Induced Diabetes in Mice. |
Q64100894 | Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol |
Q46877758 | Antioxidant N-acetylcysteine restores systemic nitric oxide availability and corrects depressions in arterial blood pressure and heart rate in diabetic rats. |
Q37112535 | Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance |
Q40114438 | Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells |
Q49193626 | Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. |
Q37976675 | Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress |
Q41756736 | Changes in glucose metabolism and reversion of genes expression in the liver of insulin-resistant rats exposed to malathion. The protective effects of N-acetylcysteine |
Q42811499 | Chromium (VI) induces insulin resistance in 3T3-L1 adipocytes through elevated reactive oxygen species generation |
Q42811492 | Chronic insulin treatment causes insulin resistance in 3T3-L1 adipocytes through oxidative stress |
Q51366919 | Chronic stress and carbohydrate metabolism: persistent changes and slow return to normalcy in male albino rats. |
Q41587620 | Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes |
Q37408370 | Decreased Expression of Type 5 17β-Hydroxysteroid Dehydrogenase (AKR1C3) Protein Identified in Human Diabetic Skin Tissue |
Q33749358 | Diabetes mellitus: channeling care through cellular discovery |
Q36148747 | Dietary Vitamin C Intake Reduces the Risk of Type 2 Diabetes in Chinese Adults: HOMA-IR and T-AOC as Potential Mediators |
Q40245739 | Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. |
Q42442589 | Differential modulation of ROS signals and other mitochondrial parameters by the antioxidants MitoQ, resveratrol and curcumin in human adipocytes |
Q52595129 | Effect of N-Acetylcysteine on Antioxidant Defense, Oxidative Modification, and Salivary Gland Function in a Rat Model of Insulin Resistance. |
Q51718358 | Effect of cysteine dosage on erythrocyte glutathione synthesis rate in a patient with cystathionine beta synthase deficiency. |
Q35813812 | Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial |
Q40580960 | Effect of thiol antioxidant on body fat and insulin reactivity |
Q52598336 | Effects and Mechanisms of Taurine as a Therapeutic Agent. |
Q53738981 | Effects of a Carbohydrate-, Glutamine-, and Antioxidant-Enriched Oral Nutrition Supplement on Major Surgery-Induced Insulin Resistance: A Randomized Pilot Study. |
Q35023011 | Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity |
Q58547678 | Eight-Week Consumption of High-Sucrose Diet Has a Pro-Oxidant Effect and Alters the Function of the Salivary Glands of Rats |
Q35601541 | Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease |
Q33839935 | FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress |
Q82904528 | Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, i |
Q33625789 | Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options |
Q54948885 | Genetic risk score of common genetic variants for impaired fasting glucose and newly diagnosed type 2 diabetes influences oxidative stress. |
Q37314354 | Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue |
Q24655291 | Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells |
Q41681187 | Gymnemasylvestre derived compounds inhibit GSH depletion and increase cGMP and nitric oxide to attenuate advanced glycation end products induced hypertrophic growth in renal tubular epithelial cells |
Q46509808 | Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation. |
Q42701033 | Inhibition of Aldehyde Dehydrogenase 2 by Oxidative Stress Is Associated with Cardiac Dysfunction in Diabetic Rats |
Q42813874 | L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose |
Q39144225 | L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARγ expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes |
Q38025442 | L-cysteine supplementation as an adjuvant therapy for type-2 diabetes. |
Q37259229 | Leptin regulation of Hsp60 impacts hypothalamic insulin signaling |
Q35855378 | Linking mitochondrial bioenergetics to insulin resistance via redox biology |
Q35854385 | Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function |
Q36748171 | Mechanistic insights into diabetes mellitus and oxidative stress |
Q64387419 | Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells |
Q58795151 | Mitochondria-Targeted Antioxidants and Skeletal Muscle Function |
Q24678741 | N-acetylcysteine -- passe-partout or much ado about nothing? |
Q28573358 | N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats |
Q46358585 | Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes |
Q93052744 | Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine |
Q34552287 | Novel avenues of drug discovery and biomarkers for diabetes mellitus |
Q46639640 | Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model |
Q54397165 | Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. |
Q46890774 | Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. |
Q86033373 | Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study |
Q36663152 | Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus |
Q46235328 | Oxidative stress in severely obese persons is greater in those with insulin resistance. |
Q46402020 | Oxysterols increase in diabetic rats |
Q33283063 | PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism |
Q38066067 | Potential role of taurine in the prevention of diabetes and metabolic syndrome. |
Q36294734 | Protein carbonylation and adipocyte mitochondrial function. |
Q28387506 | Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure |
Q33941647 | Reactive oxygen species enhance insulin sensitivity |
Q36382700 | Reactive species and early manifestation of insulin resistance in type 2 diabetes |
Q34501837 | Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation |
Q34312980 | Review: taurine: a "very essential" amino acid. |
Q90396914 | Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes |
Q37698287 | Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis |
Q55062283 | Role of taurine on the actions of alcohol against systemic and cardiac biochemical changes in the diabetic rat. |
Q37366549 | Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders |
Q26775403 | Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications |
Q44935497 | Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine |
Q50507100 | Targeting of mitochondrial reactive oxygen species production does not avert lipid-induced insulin resistance in muscle tissue from mice. |
Q36431073 | Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes |
Q42882880 | Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo |
Q28567907 | Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation |
Q47911200 | The Effect of Metformin and Taurine, Alone and in Combination, on the Oxidative Stress Caused by Diabetes in the Rat Brain |
Q89719234 | The Effect of N-Acetylcysteine on Respiratory Enzymes, ADP/ATP Ratio, Glutathione Metabolism, and Nitrosative Stress in the Salivary Gland Mitochondria of Insulin Resistant Rats |
Q37291570 | The antihypertensive effect of cysteine |
Q30743520 | The antioxidant N-Acetylcysteine does not improve glucose tolerance or β-cell function in type 2 diabetes |
Q38751170 | The beneficial effects of taurine in preventing metabolic syndrome |
Q61797240 | The expression of sirtuins, superoxide dismutase, and lipid peroxidation status in peripheral blood from patients with diabetes and hypothyroidism |
Q54408659 | The lipid peroxidation end-product and oxidant 4-hydroxynonenal induces insulin resistance in rat slow-twitch skeletal muscle. |
Q34627951 | The potential usefulness of taurine on diabetes mellitus and its complications |
Q34605273 | Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. |